kringle-pharmaCo., Ltd.

NEWS

notice

Mar 28, 2007 Notice

Kringle Pharma to initiate a phase I clinical trial of recombinant human HGF for acute renal failure cooperatively with The Rogosin Institute.

Kringle Pharma to initiate a phase I clinical trial of recombinant human HGF for acute renal failure cooperatively with The Rogosin Institute.